Profil
Actuellement, Matthew Charles Perrins Hammond occupe le poste de directeur général et de directeur financier de Mail.ru Group Ltd. M. Hammond est également membre du conseil d'administration de Strike Resources Ltd. (Australie) et de PuriCore, Inc. Dans le passé, il a été stratège de groupe chez Metalloinvest Holding Co. JSC et analyste en technologie chez Credit Suisse Securities (Europe) Ltd. M. Hammond a obtenu un diplôme de premier cycle à l'université de Bristol.
Postes actifs de Matthew Hammond
| Sociétés | Poste | Début |
|---|---|---|
Realm Therapeutics, Inc.
Realm Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Part of ESSA Pharma, Inc., Realm Therapeutics, Inc. is a company that specializes in precision brain stimulation therapies to address memory loss caused by brain injury and degenerative diseases such as Alzheimer's. The company is based in Radnor, PA. The company's technology, developed at the University of Pennsylvania with DARPA funding, aims to enhance memory, reduce disability, and boost productivity for patients. By utilizing artificial intelligence to analyze brain activity patterns, the company's device delivers personalized stimulation to improve memory performance. The company is currently in the preclinical testing phase and is preparing for FDA approval to conduct clinical trials for patients with memory loss from traumatic brain injury. | Directeur/Membre du Conseil | - |
Anciens postes connus de Matthew Hammond
| Sociétés | Poste | Fin |
|---|---|---|
| STRIKE RESOURCES LIMITED | Directeur/Membre du Conseil | 27/09/2024 |
Quanergy Perception Technologies, Inc.
Quanergy Perception Technologies, Inc. Aerospace & DefenseElectronic Technology Develops and manufactures light detection and sensors & dimensional sensing solutions | Directeur/Membre du Conseil | 30/09/2022 |
| VK COMPANY LIMITED | Directeur Général | 13/12/2021 |
| REALM THERAPEUTICS PLC | Directeur/Membre du Conseil | 17/11/2017 |
| QIWI PLC | Directeur/Membre du Conseil | 29/09/2014 |
Formation de Matthew Hammond
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
Strike Resources Ltd. (Australia)
Strike Resources Ltd. (Australia) SteelNon-Energy Minerals Engages in the exploration and evaluation of iron ore projects | Non-Energy Minerals |
Realm Therapeutics Plc
Realm Therapeutics Plc Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that develops proprietary immunomodulatory products | Health Technology |
Quanergy Perception Technologies, Inc.
Quanergy Perception Technologies, Inc. Aerospace & DefenseElectronic Technology Develops and manufactures light detection and sensors & dimensional sensing solutions | Electronic Technology |
Credit Suisse Securities (Europe) Ltd.
Credit Suisse Securities (Europe) Ltd. Investment Banks/BrokersFinance Provides brokerage services | Finance |
University of Bristol
University of Bristol Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Nautilus Minerals, Inc.
Nautilus Minerals, Inc. Precious MetalsNon-Energy Minerals Engages in the exploration of ocean floor for copper, gold, silver and zinc deposits activities | Non-Energy Minerals |
QIWI Plc
QIWI Plc Miscellaneous Commercial ServicesCommercial Services Provides payment processing services | Commercial Services |
VK International PJSC
VK International PJSC Internet Software/ServicesTechnology Services Operates communication and social platforms | Technology Services |
Realm Therapeutics, Inc.
Realm Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Part of ESSA Pharma, Inc., Realm Therapeutics, Inc. is a company that specializes in precision brain stimulation therapies to address memory loss caused by brain injury and degenerative diseases such as Alzheimer's. The company is based in Radnor, PA. The company's technology, developed at the University of Pennsylvania with DARPA funding, aims to enhance memory, reduce disability, and boost productivity for patients. By utilizing artificial intelligence to analyze brain activity patterns, the company's device delivers personalized stimulation to improve memory performance. The company is currently in the preclinical testing phase and is preparing for FDA approval to conduct clinical trials for patients with memory loss from traumatic brain injury. | Commercial Services |
















